- Hemispherx Biopharma Home Page [IA][Direct] -
Biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is presently undergoing clinical trials in the United States and Europe for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Aside from ME/CFS, Ampligen is being developed clinically for use in treating two other anti-viral indications, namely, chronic hepatitis B virus (HBV) infection and human immunodeficiency virus (HIV) associated disorders.
- Investor Relations [IA][Direct]
- News [IA][Direct]
- Products and Services [IA][Direct]
|